KBIO COMPANY Inc.

A038530

KR7038530002

Drug Retailers

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
262 ^KRW	+4.38%		-3.32%	-6.76%

2023	Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd.	CI

LaMar Holdings Co.Ltd acquired 8.23% stake in CoreCross, Inc..

March 24, 2015 at 09:30 am IST

LaMar Holdings Co.Ltd acquired 8.23% stake in CoreCross, Inc. (KOSDAQ:A038530) on March 24, 2015. LaMar acquired 2.9 million shares in the transaction.

LaMar Holdings Co.Ltd completed the acquisition of 8.23% stake in CoreCross, Inc. (KOSDAQ:A038530) on March 24, 2015.

Latest news about KBIO COMPANY Inc.

Gold Pacific Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
INCON Co.,Ltd. announced that it has received KRW 10 billion in funding from Gold Pacific Co., Ltd.	10/22/10	CI
Gold Pacific Co., Ltd. announced that it has received KRW 10.1 billion in funding	24/21/24	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Ellim Corporation Co., Ltd. and other investors	19/21/19	CI
Gold Pacific Co., Ltd. agreed to acquire Distribution Business of CureBio Co.,Ltd. for KRW 6.5 billion.	01/21/01	CI
Gold Pacific Co., Ltd. announced that it has received KRW 8.001 billion in funding from Elim Corporation	09/21/09	CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding	22/21/22	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding	19/21/19	CI
Arthur Mine Fund and Flare Fund acquired 9.6% stake in Jokwang ILI Co., Ltd. from Gold Pacific Co., Ltd. for KRW 9.7 billion.	10/20/10	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10.000084 billion in funding from Elim Corporation	12/20/12	CI
Gold Pacific Co., Ltd. announced that it has received KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd	17/20/17	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Chorokbaem Media Co., Ltd., Philosys Healthcare Co., Ltd	08/20/08	CI
Gold Pacific Co., Ltd. cancelled the acquisition of an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd.	29/20/29	CI
Gold Pacific Co., Ltd. announced that it has received KRW 6 billion in funding	12/20/12	CI
Gold Pacific Co., Ltd. announced that it expects to receive KRW 10 billion in funding	24/20/24	CI
Kim Woo-dong, Gold Pacific Co., Ltd. and two others completed the acquisition of 41.33% stake in Jokwang ILI Co., Ltd. from Lim Man-soo and five others.	14/19/14	CI
Cornerstone Networks CO., LTD announced that it has received KRW 1.5 billion in funding from Gold Pacific Co., Ltd.	12/19/12	CI
Kim Woo-dong, Gold Pacific Co., Ltd. and two others entered into an agreement to acquire 41.33% stake in Jokwang ILI Co., Ltd. from Lim Man-soo and five others for KRW 40.9 billion.	14/19/14	CI
Incon Co., Ltd. announced that it has received KRW 9 billion in funding from River Stone Co., Ltd., Gold Pacific Co., Ltd.	29/19/29	CI
Gold Pacific Co., Ltd. entered into an agreement to acquire an additional 16.4% stake in Incon Co., Ltd. from H.Anderson Co., Ltd. for KRW 44.2 billion.	29/19/29	CI
Gold Pacific Co., Ltd. completed the acquisition of Danaun Co., Ltd.	01/19/01	CI
Gold Pacific Co., Ltd. announced that it has received KRW 3.5 billion in funding	01/19/01	CI
Gold Pacific Co., Ltd. entered into an agreement to acquire Danaun Co., Ltd. for KRW 10.5 billion.	21/19/21	CI
An unknown buyer cancelled the acquisition of 6.1% stake in PangSky Co., Ltd. from Gold Pacific Co., Ltd..	20/19/20	CI
Incon Co., Ltd. announced that it expects to receive KRW 10.00000084 billion in funding from River Stone Co., Ltd., Gold Pacific Co., Ltd.	23/19/23	CI

Chart KBIO COMPANY Inc.

Duration

Period

More charts

Company Profile

KBio Company Inc, formerly Gold Pacific Co Ltd, is a Korea-based company primarily engaged in the bio distribution business. The Company operates its business through three segments. The Bio Distribution segment is engaged in the supply of research reagents and consumables to each customer through hospitals, universities, research institutes, and dealers. The Fashion segment is engaged in the production and sale of products such as handmade leather goods, clothing, and accessories. The Other segment is engaged in the fashion promotion business and other businesses.

Sector

Drug Retailers

Calendar

09/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Drug Retailers

	1st Jan change	Capi.
KBIO COMPANY INC.	-6.76%	2.13Cr
WALGREENS BOOTS ALLIANCE, INC.	-39.74%	1.38TCr
JD HEALTH INTERNATIONAL INC.	-26.34%	1.15TCr
YIFENG PHARMACY CHAIN CO., LTD.	+14.31%	640.59Cr
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-20.28%	632.32Cr
MATSUKIYOCOCOKARA & CO.	-11.33%	597.15Cr
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+72.00%	499.75Cr
NAHDI MEDICAL COMPANY	-3.36%	463.07Cr
CLICKS GROUP LIMITED	-6.21%	396.28Cr
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-18.47%	324.16Cr